TABLE 3.
Some antibacterial, anticancer, and drug delivery applications of nanoparticles.
| Type of nanoparticles | Antibacterial | Cytotoxic | Drug delivery | Reference |
|---|---|---|---|---|
| Fe-doped ZnO | Staphylococcus aureus and Bacillus subtilis | — | — | Ravichandran et al. (2017) |
| Fe-doped ZnO | — | — | Basith et al. (2016) | |
| Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus ATCC, Salmonella typhi MTCC, Staphylococcus aureus ATCC, and Candida albicans ATCC | ||||
| Fe-doped ZnO | Eschericia coli | — | — | Gambang (n.d.) |
| Fe-doped Mn3O4 | Escherichia coli | — | — | Belkhedkar and Ubale, (2016) |
| Fe-doped bioactive glass | S. aureus NCIMB-17 and E. coli NCIMB-1 | Osteosarcoma U2OS cells | — | Gupta et al. (2018) |
| Fe-doped ZnO | Escherichia coli (E.coli) and Pseudomonas aeruginosa | — | — | Kayani et al. (2018) |
| Fe-doped ZnO | Escherichia coli and Candida albicans | — | — | Chai et al. (2019) |
| Fe-doped brushite bone cements | Staphylococcus aureus strain, Escherichia coli strain, and Pseudomonas aeruginosa strain | — | — | Li et al. (2018) |
| Cu–Fe bimetallic | S. aureus, E. coli, and P. aeruginosa | — | — | Bakina et al. (2019) |
| Fe-doped ZnO | Staphylococcus aureus and Escherichia coli bacterial strains | MCF 7 cell lines | — | Sekar et al. (2019) |
| Fe-doped ceria | Neuroblastoma cancer cells and HEK-293 healthy cells | — | Abbas et al. (2015) | |
| Fe-based stents | Mammalian cells | — | Fagali et al. (2015) | |
| Fe and Nd–Fe–B alloy as core carbon shells | Human bone-derived cells | — | Wozniak et al. (2006) | |
| Fe70Pd30 nanotubes | — | IEC-6 cells* | Paracetamol | Rožman et al. (2012) |
| SMI-100 cells** |